Advertisement
Home »

Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.

Oct 30, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE EXPERTS

  • Sijian Yu

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Yu Zhang

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Guopan Yu

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Yu Wang

    Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China.

    Ruoyang Shao

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Xin Du

    Peking Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.

    Na Xu

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Dongjun Lin

    Department of Hematology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.

    Weihua Zhao

    Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

    Xiong Zhang

    Department of Hematology, Maoming People’s Hospital, Maoming, China.

    Jie Xiao

    Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

    Zhiqiang Sun

    Department of Hematology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.

    Lan Deng

    Department of Hematology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

    Xinquan Liang

    Department of Hematology, The First People’s Hospital of Chenzhou, Chenzhou, China.

    Hongyu Zhang

    Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.

    Ziwen Guo

    Department of Hematology, Zhongshan City People’s Hospital, Zhongshan, China.

    Min Dai

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Pengcheng Shi

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Fen Huang

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Zhiping Fan

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Qiong Liu

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Ren Lin

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Xuejie Jiang

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Li Xuan

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Qifa Liu

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

    Hua Jin

    Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

    Clinical Medical Research Center of Hematology Diseases of Guangdong Province, Guangzhou, China.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement